<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Friday, Nov. 2, 2007</title>
	<atom:link href="http://venturebeat.com/2007/11/02/life-sciences-briefing-friday-nov-2-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/11/02/life-sciences-briefing-friday-nov-2-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Tue, 24 Nov 2009 05:47:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Tuesday, Nov. 20, 2007</title>
		<link>http://venturebeat.com/2007/11/02/life-sciences-briefing-friday-nov-2-2007/comment-page-1/#comment-643400</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Tuesday, Nov. 20, 2007</dc:creator>
		<pubDate>Tue, 20 Nov 2007 21:22:04 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/11/02/life-sciences-briefing-friday-nov-2-2007/#comment-643400</guid>
		<description>[...] vaccine maker raised $12 million in its first funding round. That appears to contradict an earlier item from PE Hub that said Juvaris BioTherapeutics had raised $16 million, according to a regulatory [...]</description>
		<content:encoded><![CDATA[<p>[...] vaccine maker raised $12 million in its first funding round. That appears to contradict an earlier item from PE Hub that said Juvaris BioTherapeutics had raised $16 million, according to a regulatory [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
